Skip to main content

Table 2 Take rates in glioblastoma group and survival time of tumor-bearing mice.

From: Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar

Generation No. of mice No. of tumor-bearing mice1 Take rate(%) survival time(d)
1 10 9 90 32.4 ± 2.1
2 10 9 90 30.4 ± 2.2
3 10 10 100 29.9 ± 2.1
4 10 10 100 28.4 ± 2.7
5 10 10 100 23.9 ± 1.7
6 10 10 100 23.0 ± 0.9
7 10 10 100 22.8 ± 1.3
8 10 10 100 21.7 ± 1.3
9 10 10 100 23.2 ± 0.6
10 10 10 100 22.0 ± 1.8
11 10 10 100 21.3 ± 1.2
12 10 10 100 21.4 ± 1.8
13 10 10 100 22.4 ± 0.9
  1. 1Each mouse was implanted with one graft(Site: right caudate nucleus of nude mice)
  2. Take rates in glioblastoma group and survival time of tumor-bearing mice in the intracranial xenotransplantation